Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Progress in Neurobiology
|
November 21, 2009
Parkinson's disease: Exit toxins, enter genetics
Marie Westerlund, Barry Hoffer, Lars Olson
Experimental Neurology
|
November 17, 2012
Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat
Katharine Eakin, Barry Hoffer, Jonathan Miller
Parkinsonism & Related Disorders
|
January 20, 2010
How useful are stem cells in PD therapy?
Yu Luo, Serena Y Kuang, Barry Hoffer
International Journal of Molecular Sciences
|
September 5, 2015
Mitochondria: A Therapeutic Target for Parkinson's Disease?
Yu Luo, Alan Hoffer, Barry Hoffer, et al.
Scientific Reports
|
September 14, 2016
Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson's disease model induced by MPTP
Emily Filichia, Barry Hoffer, Xin Qi, et al.
Parkinsonism & Related Disorders
|
December 15, 2011
Neurorestoration
Mikko Airavaara, Merja H Voutilainen, Yun Wang, et al.
Parkinsonism & Related Disorders
|
September 20, 2011
WITHDRAWN: Neurorestoration
Mikko Airavaara, Merja H Voutilainen, Yun Wang, et al.
Cell Transplantation
|
November 9, 2017
Improving Neurorepair in Stroke Brain Through Endogenous Neurogenesis-Enhancing Drugs
Kuo-Jen Wu, Seongjin Yu, Jea-Young Lee, et al.
Plos One
|
December 15, 2010
Decreased level of Nurr1 in heterozygous young adult mice leads to exacerbated acute and long-term toxicity after repeated methamphetamine exposure
Yu Luo, Yun Wang, Serena Y Kuang, et al.
Brain Research
|
September 30, 2008
Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFR alpha1, gene
Heather A Boger, Lawrence D Middaugh, Vandana Zaman, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Progress in Neurobiology
|
November 21, 2009
Parkinson's disease: Exit toxins, enter genetics
Marie Westerlund, Barry Hoffer, Lars Olson
Experimental Neurology
|
November 17, 2012
Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat
Katharine Eakin, Barry Hoffer, Jonathan Miller
Parkinsonism & Related Disorders
|
January 20, 2010
How useful are stem cells in PD therapy?
Yu Luo, Serena Y Kuang, Barry Hoffer
International Journal of Molecular Sciences
|
September 5, 2015
Mitochondria: A Therapeutic Target for Parkinson's Disease?
Yu Luo, Alan Hoffer, Barry Hoffer, et al.
Scientific Reports
|
September 14, 2016
Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson's disease model induced by MPTP
Emily Filichia, Barry Hoffer, Xin Qi, et al.
Parkinsonism & Related Disorders
|
December 15, 2011
Neurorestoration
Mikko Airavaara, Merja H Voutilainen, Yun Wang, et al.
Parkinsonism & Related Disorders
|
September 20, 2011
WITHDRAWN: Neurorestoration
Mikko Airavaara, Merja H Voutilainen, Yun Wang, et al.
Cell Transplantation
|
November 9, 2017
Improving Neurorepair in Stroke Brain Through Endogenous Neurogenesis-Enhancing Drugs
Kuo-Jen Wu, Seongjin Yu, Jea-Young Lee, et al.
Plos One
|
December 15, 2010
Decreased level of Nurr1 in heterozygous young adult mice leads to exacerbated acute and long-term toxicity after repeated methamphetamine exposure
Yu Luo, Yun Wang, Serena Y Kuang, et al.
Brain Research
|
September 30, 2008
Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFR alpha1, gene
Heather A Boger, Lawrence D Middaugh, Vandana Zaman, et al.
Page
of 3